Covered recipient · General Payments record
SATNAM MAHAL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2023
$3,138.85
- Reported across 227 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $205.70 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $44.82 | 2 |
| ABBVIE INC. | $37.74 | 2 |
| Indivior Inc. | $33.70 | 2 |
| Corium, Inc. | $26.02 | 2 |
| Janssen Pharmaceuticals, Inc | $17.90 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.95 | 1 |
| ITI, Inc. | $14.40 | 1 |
| Neurocrine BioSciences, Inc. | $14.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.05 | 01/31/2023 | Food and Beverage | Undisputed | 06/30/2026 | 997816231 | CMS |
| ABBVIE INC. | $17.69 | 02/28/2023 | Food and Beverage | Undisputed | 06/30/2026 | 997816233 | CMS |
| Corium, LLC | $10.20 | 01/24/2023 | Food and Beverage | Undisputed | 06/30/2026 | 977918543 | CMS |
| Corium, LLC | $15.82 | 02/27/2023 | Food and Beverage | Undisputed | 06/30/2026 | 977918555 | CMS |
| Indivior Inc. | $19.98 | 01/21/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034245921 | CMS |
| Indivior Inc. | $13.72 | 02/21/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034245929 | CMS |
| ITI, Inc. | $14.40 | 02/04/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1040606457 | CMS |
| Janssen Pharmaceuticals, Inc | $17.90 | 02/06/2023 | Food and Beverage | Undisputed | 06/30/2026 | 987837779 | CMS |
| Neurocrine Biosciences, Inc. | $14.17 | 02/14/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1052084229 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.42 | 02/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1014530609 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.40 | 02/24/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1014530621 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.95 | 02/07/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1056769655 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.